• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Intravenous chemotherapy risks accumulate at inter-stage transitions, qualitative study finds

by
November 11, 2026
in Health
Reading Time: 2 mins read
0
Intravenous chemotherapy risks accumulate at inter-stage transitions, qualitative study finds

Intravenous chemotherapy risks accumulate at inter-stage transitions, qualitative study finds

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Safety risks in intravenous chemotherapy do not concentrate within any single operational stage but instead accumulate and transmit in a chain-like pattern at inter-stage junctions, according to a qualitative descriptive study conducted at a tertiary hospital in Suzhou, China. The research evaluated safety vulnerabilities across the clinical medication trajectory by gathering direct evidence from healthcare professionals and patients rather than examining clinical tasks in isolation.

The investigation utilized the World Health Organization medication-use process alongside Hazard Analysis and Critical Control Points principles as an analytical framework to map how hazards emerge and propagate. Semi-structured interviews were conducted between April and September 2025 at a tertiary hospital in Suzhou, China. Researchers analyzed the resulting interview data using directed content analysis in NVivo version 15.0 and structured their reporting according to the Consolidated Criteria for Reporting Qualitative Research guidelines.

The study engaged a purposive, multi-stakeholder sample consisting of 13 oncology nurses, seven physicians, three pharmacists, and 11 patients. By synthesizing insights across these distinct clinical roles and care recipients, the research team identified safety vulnerabilities that extended beyond the observational scope of single-profession or stage-confined assessments.

Across the four core chemotherapy phases of prescribing, compounding, administration, and monitoring, the analysis classified four primary themes and 13 subthemes. These findings exposed stage-specific vulnerabilities centered around information integrity, process verification, implementation consistency, and continuity of care across the treatment continuum.

The study identified three cross-cutting mechanisms underpinning risk transmission between clinical junctions: information discontinuity, where incomplete patient details pass unverified across hospital stages and external healthcare institutions; accountability gaps, where risks lack clear ownership during care handovers and following patient discharge; and procedural-implementation deviation, wherein safety checks remain documented in form but are weakened in actual protective function under real-world operational constraints.

Based on these observations, the authors concluded that hospital safety management should extend beyond measuring compliance within isolated stages to actively safeguarding inter-stage connections by verifying patient records at every transition, clarifying professional responsibilities across care environments, and assessing whether safety checks fulfill their intended verification purpose. Because the investigation was conducted at a single tertiary center, the authors noted that their conceptual risk-transmission framework requires further validation through multicentre and quantitative studies.

Prior evaluations of intravenous chemotherapy administration have largely concentrated on discrete stages or individual professional silos, leaving the systemic mechanisms of risk accumulation across interconnected care transitions insufficiently characterised.

Subject of Research: Intravenous chemotherapy administration safety and inter-stage risk transmission

Article Title: Key risk factors in intravenous chemotherapy administration safety: a multi-stakeholder qualitative study

Article References: Liu, D., Wang, Q., Wang, X., Yuan, Y., Wang, F., Xu, L., & Tong, Y. (2026). Key Risk Factors in Intravenous Chemotherapy Administration Safety: A Multi-Stakeholder Qualitative Study. Frontiers in Health Services, 6, 1971730. https://doi.org/10.3389/frhs.2026.1971730

Image Credits: AI Generated

DOI: 10.3389/frhs.2026.1971730

Keywords: intravenous chemotherapy, chemotherapy administration, medication safety, patient safety, qualitative research, Hazard Analysis and Critical Control Points, HACCP, WHO medication-use process, inter-stage risk transmission, oncology nursing, clinical handovers, directed content analysis, COREQ, information discontinuity, accountability gaps, procedural deviation, chemotherapy compounding, treatment monitoring

News Source: Nathaniel Bowman. (November 11, 2026). Intravenous chemotherapy risks accumulate at inter-stage transitions, qualitative study finds. Scienmag.

Tags: accountability gapschemotherapy administrationchemotherapy compoundingclinical handoversCOREQdirected content analysisHACCPHazard Analysis and Critical Control Pointsinformation discontinuityinter-stage risk transmissionintravenous chemotherapyMedication safetyOncology nursingPatient Safetyprocedural deviationqualitative researchtreatment monitoringWHO medication-use process
Share12Tweet7Share2ShareShareShare1

Related Posts

Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

November 17, 2026
Specialized EBI3-High Dendritic Cell Subset Identified in Rheumatoid Arthritis Synovial Fluid

Specialized EBI3-High Dendritic Cell Subset Identified in Rheumatoid Arthritis Synovial Fluid

November 17, 2026

Early Tildrakizumab Treatment Predicts Complete Psoriasis Clearance in Five-Year Italian Study

November 17, 2026

Obsessive-Compulsive Disorder Patients Show Altered Emotional Processing and Oculomotor Control Patterns

November 17, 2026

POPULAR NEWS

  • Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

    Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

    29 shares
    Share 12 Tweet 7
  • Nanjing Hospital Study Finds 19.2 Percent HPV Positivity Among 39,335 Women

    29 shares
    Share 12 Tweet 7
  • Specialized EBI3-High Dendritic Cell Subset Identified in Rheumatoid Arthritis Synovial Fluid

    29 shares
    Share 12 Tweet 7
  • Early Tildrakizumab Treatment Predicts Complete Psoriasis Clearance in Five-Year Italian Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

Nanjing Hospital Study Finds 19.2 Percent HPV Positivity Among 39,335 Women

Specialized EBI3-High Dendritic Cell Subset Identified in Rheumatoid Arthritis Synovial Fluid

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.